Announcements Trials

Browse Landscape

Phase

Phase NA 4 Phase 4 1 Phase 3 1 Phase 2 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Unilateral U/S PVB 1 Stomach Neoplasms 1 Pain, Postoperative 1 Lung Neoplasms 1 Liver Neoplasms 1 Liver Diseases 1 Head and Neck Neoplasms 1 Epstein-Barr Virus Infections 1 Diarrhea 1 Colorectal Neoplasms 1 Colonic Neoplasms 1 Carcinoma, Non-Small-Cell Lung 1 Carcinoma, Hepatocellular 1 Breast Neoplasms 1

Interventions

Bismuth 6 Esomeprazole 5 Amoxicillin 5 Tetracycline 4 Oxaliplatin 4 apatinib 3 Irinotecan 3 Furazolidone 3 Fluorouracil 3 Clarithromycin 3 fish oil triglycerides 2 Rabeprazole 2 Leucovorin 2 Indocyanine Green 2 Berberine 2 sintilimab 1 potassium oxonate 1 lenvatinib 1 iron isomaltoside 1000 1 ilaprazole 1 gimeracil 1 ferric carboxymaltose 1 doxifluridine 1 alanylglutamine 1 Water 1 Trastuzumab 1 Tranexamic Acid 1 Tobacco Use Cessation Devices 1 Thalidomide 1 Tegafur 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 4 × Stomach Neoplasms × Control Groups × Clear all

NCT05645198 2022-12-09

OOZFIX

Bucheon St. Mary's Hospital

Phase 4 Unknown

Gastrointestinal

Stomach Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡